MedPro Safety Products, Inc. Receives CE Mark for its Blood Collection Safety Products
Published: Jul 12, 2011
“The CE Mark is another important milestone for MedPro, allowing for the expansion of sales of the VACUETTE® blood collection devices into large and growing markets in Europe,” said Craig Turner, Chairman and CEO of MedPro Safety Products. “We believe our patented passive needlestick technology is a compelling feature that will be well received by healthcare professionals in Europe as it has been in the United States. The CE Mark, along with the 510(K) clearance that we received from the Food and Drug Administration (FDA) last year, has positioned us well to grow our presence globally.”
The World Health Organization (WHO) estimates that worldwide, approximately three million healthcare employees, roughly 10% of the global industry’s workforce, are exposed to bloodborne pathogens as a result of a needlestick injury each year.
MedPro Safety’s devices are based on patented technology that offers healthcare professionals the safety of sample collection through a truly passive needlestick prevention feature that automatically activates through normal use, without the requirement of any additional step by the user. The VACUETTE® PREMIUM Safety Needle System Tube-Touch is equipped with a shield that automatically covers the needle during the blood collection process.
The devices are manufactured, marketed and distributed globally by Greiner Bio-One, an international manufacturer and supplier of medical devices and pre-analytic products. The VACUETTE® PREMIUM Safety Needle System Tube-Touch was released to the market in April in the United States.
About MedPro Safety Products, Inc.
Headquartered in Lexington, Kentucky, MedPro Safety Products, Inc. is a leading developer of safer medication delivery and blood collection systems. The Company licenses, develops and manufactures transformational technologies marketed through its global medical device partners. MedPro’s products address multiple product categories within the medication delivery (injection and infusion) and blood collection (blood collection sets and blood tube holders) markets. Unlike competitive products currently available on the market, MedPro’s products incorporate safety features that operate without user activation, and therefore require little or no clinician training to use. The total global market opportunity for safer medication delivery and blood collection products is believed to be more than $6 billion. For additional information, please refer to the ‘Investor Relations’ link on the Company’s website (www.medprosafety.com).
Safe Harbor Statement
This release includes forward-looking statements based upon current expectations of the management of MedPro Safety Products, Inc. that involve risks and uncertainties, such as plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including our ability to identify and acquire medical safety device safety technologies with product development potential; our ability to successfully develop and bring products to market, including obtaining regulatory approvals; our ability to successfully increase sales of our products; our ability to obtain additional financing on satisfactory terms; our ability to attract and retain qualified employees; and governmental regulation associated with the medical safety products industry. Words such as "anticipate," "estimate," "plan," "continuing," "ongoing," "expect," "believe," "intend," "may," "will," "should," "could," and similar expressions are used to identify forward-looking statements. We refer you to the more detailed discussion of risks and uncertainties under "Risk Factors" in our Annual Report on Form 10-K and our other reports on file with the Securities and Exchange Commission.